Pregnancy and malaria: the perfect storm
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Purpose of review: Malaria in pregnancy continues to exert a toll on pregnant women and their offspring. Recent findings: The burden of Plasmodium falciparum infection is especially large in Africa, and new data show lasting effects of maternal infection on the infant's neurocognitive development. Elsewhere, P. vivax infection causes relapsing infections that are challenging to prevent. Infection in first trimester of pregnancy is an area of increasing focus, and its adverse effects on pregnancy outcome are increasingly recognised. First-trimester infection is common and frequently acquired prior to conception. Although newer rapid diagnostic tests still have limited sensitivity, they may be useful in detection of early pregnancy malaria for treatment. Artemisinin-based combination therapies are efficacious in later pregnancy but have yet to be recommended in first trimester because of limited safety data. In Africa, intermittent preventive treatment in pregnancy (IPTp) with monthly sulfadoxine-pyrimethamine improves pregnancy outcomes, but sulfadoxine-pyrimethamine resistance is worsening. The alternative, IPTp with dihydroartemisinin-piperaquine, has greater antimalarial efficacy, but does not appear to improve pregnancy outcomes, because sulfadoxine-pyrimethamine has poorly understood nonmalarial benefits on birthweight. Summary: Novel IPTp regimens must be combined with interventions to strengthen protection from malaria infection acquired before and in early pregnancy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is in line with studies conducted earlier in the region and the report presented by the World Health Organization [2, 18–20].”
From Malaria in pregnancy: Meta-analyses of prevalence and associated complications (2024) · cites this paper as [20]
Citations
Cites
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention
Chandramohan, D., Zongo, I., Sagara, I., Cairns, M., Yerbanga, R.-S., Diarra, M., Nikièma, F., Tapily, A., Sompougdou, F., Issiaka, D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2026330 · Cited by 236
Burt, J. F., Ouma, J., Lubyayi, L., Amone, A., Aol, L., Sekikubo, M., Nakimuli, A., Nakabembe, E., Mboizi, R., Musoke, P., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-006102 · Cited by 184 · cited 1×
“Sulfadoxine-pyrimethamine has been shown tomarkedly reduce LBW, but uptake of IPTp remains suboptimal [49] and was affected by the COVID-19 pandemic [50].”
BackgroundMordmüller, B., Sulyok, M., Egger-Adam, D., Resende, M., de Jongh, W. A., Jensen, M. H., Smedegaard, H. H., Ditlev, S. B., Soegaard, M., Poulsen, L., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1140 · Cited by 154 · cited 1×
“The vaccines incorporated sequences from the VAR2CSA protein implicated in placental binding [25,26].”
BackgroundSirima, S. B., Richert, L., Chêne, A., Konate, A. T., Campion, C., Dechavanne, S., Semblat, J.-P., Benhamouda, N., Bahuaud, M., Loulergue, P., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30739-x · Cited by 124
Amimo, F., Lambert, B. C., Magit, A. E., Sacarlal, J., Hashizume, M., & Shibuya, K. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003217 · Cited by 105 · cited 2×
“The combination of vaccination with RTS,S and monthly chemoprevention was superior to either intervention alone in young West African children.”
BackgroundCutts, J. C., Agius, P. A., Lin, Z., Powell, R., Moore, K. A., Draper, B. L., Simpson, J. A., & Fowkes, F. J. I. (2020) · BMC Medicine · doi:10.1186/s12916-019-1467-6 · Cited by 102
Roh, M. E., ter Kuile, F. O., Rerolle, F., Glymour, M. M., Shiboski, S. C., Gosling, R. D., Gutman, J., Kakuru, A., Desai, M. R., Kajubi, R., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30119-4 · Cited by 82
Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA.
Ma, R., Lian, T., Huang, R., Renn, J. P., Petersen, J. D., Zimmerberg, J., Duffy, P. E., & Tolia, N. H. (2021) · Nature Microbiology · doi:10.1038/s41564-020-00858-9 · Cited by 72
Larsen, M. D., Lopez-Perez, M., Dickson, E. K., Ampomah, P., Ndam, N. T., Nouta, J., Koeleman, C. A. M., Ederveen, A. L. H., Mordmüller, B. G., Salanti, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26118-w · Cited by 67
Wang, K., Dagil, R., Lavstsen, T., Misra, S. K., Spliid, C. B., Wang, Y., Gustavsson, T., Sandoval, D. R., Vidal-Calvo, E. E., Choudhary, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23254-1 · Cited by 52
Cited by
Poespoprodjo, J. R., Douglas, N. M., Ansong, D., Kho, S., & Anstey, N. M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01249-7 · Cited by 204
The emergence of artemisinin partial resistance in Africa: how do we respond?
Rosenthal, P. J., Asua, V., Bailey, J. A., Conrad, M. D., Ishengoma, D. S., Kamya, M. R., Rasmussen, C., Tadesse, F. G., Uwimana, A., & Fidock, D. A. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00141-5 · Cited by 180
Shi, D., Wei, L., Liang, H., Yan, D., Zhang, J., & Wang, Z. (2023) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s419616 · Cited by 40
“Malaria infection during pregnancy can lead to various adverse outcomes such as maternal anemia, preterm delivery, fetal loss, low birth weight, and cognitive impairment in newborns.(25,26) One in four pregnant women in malaria-endemic African malariaendemic areas was believed to carry a malaria infection at the time…”
BackgroundMalaria in pregnancy: Meta-analyses of prevalence and associated complications
Das, J. K., Lakhani, S., Rahman, A. R., Siddiqui, F., Ali Padhani, Z., Rashid, Z., Mahmud, O., Naqvi, S. K., Amir Naseem, H., Jehanzeb, H., et al. (2024) · Epidemiology and Infection · doi:10.1017/s0950268824000177 · Cited by 31
“There was no change in effect observed during sensitivity analysis (Supplementary Appendix Fig ure 20).”
BackgroundResultGaaloul, M. E., Tchouatieu, A.-M., Kayentao, K., Campo, B., Buffet, B., Ramachandruni, H., Ndiaye, J. L., Wells, T. N. C., Audibert, C., Achan, J., et al. (2024) · Malaria Journal · doi:10.1186/s12936-024-05128-1 · Cited by 25
“IPTp with at least three courses of SP is recommended after week 13 of pregnancy to protect women and reduce adverse outcomes [2, 46].”
Background
Metadata
- Authors
- Rogerson, S. J., & Unger, H. W.
- Affiliations
- The University of Melbourne (AU)
- Liverpool School of Tropical Medicine (GB)
- Corresponding author
- Rogerson, Stephen J.
- Venue
- Current Opinion in Infectious Diseases
- Published
- 2022-07-22
- Volume
- 35
- Issue
- 5
- Pages
- 410-416
- ISSN
- 0951-7375 (ISSN-L)
- 1473-6527
- OpenAlex
- W4289447720
- Cited by
- 17
- References
- 62
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 9 · 2023: 3
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- malaria in pregnancy, Plasmodium falciparum, Plasmodium vivax, intermittent preventive treatment in pregnancy, sulfadoxine-pyrimethamine, dihydroartemisinin-piperaquine, artemisinin-based combination therapy, rapid diagnostic tests, birth weight, pregnancy outcomes, sulfadoxine-pyrimethamine resistance
- MeSH terms
- Antimalarials, Drug Combinations, Female, Humans, Malaria, Pregnancy, Pregnancy Outcome, Pregnancy Complications, Parasitic, Malaria, Falciparum, Malaria, Vivax
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pregnancy and malaria: the perfect storm. https://app.cochat.ai/papers/10.1097/qco.0000000000000859
- The paper
- Rogerson, S. J., & Unger, H. W. (2022). Pregnancy and malaria: the perfect storm. Current Opinion in Infectious Diseases. https://doi.org/10.1097/qco.0000000000000859
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.